NASDAQ:SGEN
Seagen Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.seagen.comcrunchbase
seattle-geneticslinkedin
seagenfounding date
Jan 01, 1998ipo date
Mar 09, 2001
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothel...Show More
Earnings
Earnings Release in 2 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus